Devin Absher has been a productive scientist in genetics and genomics for over 20 years, after completing his Ph.D. at Emory University and a postdoctoral fellowship at Stanford University. His research has involved the pursuit of genetic and epigenetic contributors to complex human traits and diseases, with a focus on cardiometabolic disease and autoimmunity. As a researcher, he has contributed to over 200 peer-reviewed publications.
In addition to his research, Dr. Absher has also been involved the clinical implementation of genetics, leading the Genomic Health program at the HudsonAlpha Institute for Biotechnology. Under his leadership, the program developed and deployed pharmacogenetic and precision oncology clinical testing for use in diverse clinical settings, including community and rural health systems. These programs offered a comprehensive suite of clinical services, laboratory tests, and software tools that enabled the implementation of genomics for the benefit of patients who would otherwise not have access to precision medicine.
Devin Absher joined KP in 2022 to further both genomic research and precision medicine as VP of the Kaiser Permanente Research Bank. The Research Bank’s integration of genetic data, medical data, and health surveys, on over 400,000 KP participants, will serve as a vital resource for KP’s ground breaking research and its innovative delivery of advanced clinical care.